Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Conference News CRT 2024

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

L.A. McKeown

March 20, 2024

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

L.A. McKeown

March 29, 2023

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

News Features

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

L.A. McKeown

December 24, 2020

News Conference News VIVA 2020

As ‘Paclitaxelgate’ Loses Steam, Experts Mull Lasting Impact for Future Trials, Practice

L.A. McKeown

November 27, 2020

News Daily News

Recovered Paclitaxel PAD Data Shift the Mortality Picture

L.A. McKeown

May 14, 2020

News Daily News

Veterans Study Shows Areas of Need for CLI Care

L.A. McKeown

February 17, 2020

News Features

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

L.A. McKeown

December 12, 2019

News Daily News

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

Caitlin E. Cox

July 30, 2019

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

L.A. McKeown

December 18, 2018

News Industry News

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

November 02, 2015

News Daily News

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

L.A. McKeown

September 23, 2015

News Industry News

Medtronic Launches the Entrust(TM) Delivery System in the United States

August 06, 2015

Presentation TCT 2014

TCT 530: Effectiveness of the Misago Stent for the Treatment of Superficial Femoral Artery Disease: 12-Month Results of the First Japan and the United States Collaboration Trial (OSPREY)

Presenter: Lawrence A. Garcia, Richard M. Green, Douglas E. Drachman, Takao Ohki, MD

September 14, 2014

Advertisement

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Top Endovascular News of 2024

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

As ‘Paclitaxelgate’ Loses Steam, Experts Mull Lasting Impact for Future Trials, Practice

Recovered Paclitaxel PAD Data Shift the Mortality Picture

Veterans Study Shows Areas of Need for CLI Care

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

Medtronic Launches the Entrust(TM) Delivery System in the United States

TCT 530: Effectiveness of the Misago Stent for the Treatment of Superficial Femoral Artery Disease: 12-Month Results of the First Japan and the United States Collaboration Trial (OSPREY)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content